153 related articles for article (PubMed ID: 2156549)
1. Monoclonal antibodies against myeloperoxidase are valuable immunological reagents for the diagnosis of acute myeloid leukaemia.
van der Schoot CE; Daams GM; Pinkster J; Vet R; von dem Borne AE
Br J Haematol; 1990 Feb; 74(2):173-8. PubMed ID: 2156549
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibody anti-MPO is useful in recognizing minimally differentiated acute myeloid leukaemia.
Praxedes MK; De Oliveira LZ; Pereira Wda V; Quintana IZ; Tabak DG; De Oliveira MS
Leuk Lymphoma; 1994 Jan; 12(3-4):233-9. PubMed ID: 8167554
[TBL] [Abstract][Full Text] [Related]
3. Value of monoclonal anti-myeloperoxidase (MPO7) for diagnosing acute leukaemia.
Storr J; Dolan G; Coustan-Smith E; Barnett D; Reilly JT
J Clin Pathol; 1990 Oct; 43(10):847-9. PubMed ID: 1977771
[TBL] [Abstract][Full Text] [Related]
4. The role of an anti-myeloperoxidase antibody in the diagnosis and classification of acute leukaemia: a comparison with light and electron microscopy cytochemistry.
Buccheri V; Shetty V; Yoshida N; Morilla R; Matutes E; Catovsky D
Br J Haematol; 1992 Jan; 80(1):62-8. PubMed ID: 1311196
[TBL] [Abstract][Full Text] [Related]
5. Comparison of myeloperoxidase detection by flow cytometry using two different clones of monoclonal antibodies.
Leong CF; Kalaichelvi AV; Cheong SK; Hamidah NH; Rahman J; Sivagengei K
Malays J Pathol; 2004 Dec; 26(2):111-6. PubMed ID: 16329563
[TBL] [Abstract][Full Text] [Related]
6. Characterization of myeloid leukemia by monoclonal antibodies, with an emphasis on antibodies against myeloperoxidase.
van der Schoot CE; von dem Borne AE; Tetteroo PA
Acta Haematol; 1987; 78 Suppl 1():32-40. PubMed ID: 2829487
[TBL] [Abstract][Full Text] [Related]
7. Intracellular markers in acute myeloid leukemia diagnosis.
Koníková E; Glasová M; Kusenda J; Babusíková O
Neoplasma; 1998; 45(5):282-91. PubMed ID: 9921916
[TBL] [Abstract][Full Text] [Related]
8. Use of monoclonal antibody against human neutrophil elastase in normal and leukaemic myeloid cells.
Pulford KA; Erber WN; Crick JA; Olsson I; Micklem KJ; Gatter KC; Mason DY
J Clin Pathol; 1988 Aug; 41(8):853-60. PubMed ID: 2844860
[TBL] [Abstract][Full Text] [Related]
9. Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO).
Bennett JM; Catovsky D; Daniel MT; Flandrin G; Galton DA; Gralnick HR; Sultan C
Br J Haematol; 1991 Jul; 78(3):325-9. PubMed ID: 1651754
[TBL] [Abstract][Full Text] [Related]
10. Identification of acute myeloid leukemia in dogs using flow cytometry with myeloperoxidase, MAC387, and a canine neutrophil-specific antibody.
Villiers E; Baines S; Law AM; Mallows V
Vet Clin Pathol; 2006 Mar; 35(1):55-71. PubMed ID: 16511792
[TBL] [Abstract][Full Text] [Related]
11. Acute myeloid leukaemia with an unusual phenotype: myeloperoxidase (+), CD13 (-), CD14 (-) and CD33 (-).
Seshi B; Kashyap A; Bennett JM
Br J Haematol; 1992 Jul; 81(3):374-7. PubMed ID: 1382546
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of bone marrow specimens with acute myelogenous leukemia for CD34, CD15, CD117, and myeloperoxidase.
Dunphy CH; Polski JM; Evans HL; Gardner LJ
Arch Pathol Lab Med; 2001 Aug; 125(8):1063-9. PubMed ID: 11473459
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and prognostic significance of serum measurements of lactoferrin, lysozyme and myeloperoxidase in acute myeloid leukemia (AML): recognition of a new variant, high-lactoferrin AML.
Oberg G; Dahl R; Ellegaard J; Sundström C; Vaeth M; Venge P
Eur J Haematol; 1987 Feb; 38(2):148-55. PubMed ID: 3036571
[TBL] [Abstract][Full Text] [Related]
14. The value of detecting surface and cytoplasmic antigens in acute myeloid leukaemia.
Urbano-Ispizua A; Matutes E; Villamor N; Sierra J; Pujades A; Reverter JC; Feliu E; Cervantes F; Vives-Corrons JL; Montserrat E
Br J Haematol; 1992 Jun; 81(2):178-83. PubMed ID: 1322689
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of different permeabilization methods for the flow cytometry measurement of cytoplasmic myeloperoxidase and lysozyme in normal and leukemic cells.
Lanza F; Latorraca A; Moretti S; Castagnari B; Ferrari L; Castoldi G
Cytometry; 1997 Jun; 30(3):134-44. PubMed ID: 9222099
[TBL] [Abstract][Full Text] [Related]
16. [Immunologic characteristics and prognosis of acute myeloid leukemia M1].
Zhao F; Chen Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):687-91. PubMed ID: 17708783
[TBL] [Abstract][Full Text] [Related]
17. Myeloid enzymes profile related to the immunophenotypic characteristics of blast cells from patients with acute myeloid leukemia (AML) at diagnosis.
Klobusicka M; Kusenda J; Babusikova O
Neoplasma; 2005; 52(3):211-8. PubMed ID: 15875082
[TBL] [Abstract][Full Text] [Related]
18. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
Pituch-Noworolska A
Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
[TBL] [Abstract][Full Text] [Related]
19. Immunological detection of myeloperoxidase in poorly differentiated acute leukemia.
Lepelley P; Preudhomme C; Sartiaux C; Ghevaert C; Lai JL; Iaru T; Fenaux P; Cosson A
Eur J Haematol; 1993 Mar; 50(3):155-9. PubMed ID: 8386105
[TBL] [Abstract][Full Text] [Related]
20. [Immunocytochemistry in the diagnosis of acute myeloid leukemia (M0)].
Saito M; Kuriyama K; Nagai K; Nonaka H; Hata T; Tusima H; Tabata S; Arimura K; Souda H; Nakamura H
Rinsho Ketsueki; 1994 Nov; 35(11):1297-304. PubMed ID: 7823396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
